Search Results - "Paul, Kiran"

Refine Results
  1. 1

    Analysis of circulating breast cancer cell heterogeneity and interactions with peripheral blood mononuclear cells by Brechbuhl, Heather M., Vinod‐Paul, Kiran, Gillen, Austin E., Kopin, Etana G., Gibney, Kari, Elias, Anthony D., Hayashi, Masanori, Sartorius, Carol A., Kabos, Peter

    Published in Molecular carcinogenesis (01-10-2020)
    “…For solid tumors, extravasation of cancer cells and their survival in circulation represents a critical stage of the metastatic process that lacks complete…”
    Get full text
    Journal Article
  2. 2

    Cytokeratin 5 alters β-catenin dynamics in breast cancer cells by McGinn, Olivia, Ward, Ashley V., Fettig, Lynsey M., Riley, Duncan, Ivie, Joshua, Paul, Kiran V., Kabos, Peter, Finlay-Schultz, Jessica, Sartorius, Carol A.

    Published in Oncogene (01-03-2020)
    “…Estrogen receptor (ER) positive breast cancers often contain subpopulations of cells that express the intermediate filament protein cytokeratin 5 (CK5). CK5+…”
    Get full text
    Journal Article
  3. 3

    New generation breast cancer cell lines developed from patient-derived xenografts by Finlay-Schultz, Jessica, Jacobsen, Britta M, Riley, Duncan, Paul, Kiran V, Turner, Scott, Ferreira-Gonzalez, Andrea, Harrell, J Chuck, Kabos, Peter, Sartorius, Carol A

    Published in Breast cancer research : BCR (23-06-2020)
    “…Breast cancer is a highly heterogeneous disease characterized by multiple histologic and molecular subtypes. While a myriad of breast cancer cell lines have…”
    Get full text
    Journal Article
  4. 4

    Insulin receptor substrate-1 (IRS-1) mediates progesterone receptor-driven stemness and endocrine resistance in oestrogen receptor+ breast cancer by Dwyer, Amy R., Truong, Thu H., Kerkvliet, Carlos Perez, Paul, Kiran V., Kabos, Peter, Sartorius, Carol A., Lange, Carol A.

    Published in British journal of cancer (05-01-2021)
    “…Background Progesterone receptors (PR) are potent modifiers of endocrine responses. In aberrant signalling cancer contexts, phosphorylation events dramatically…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Cytokeratins 5 and 17 Maintain an Aggressive Epithelial State in Basal-Like Breast Cancer by McGinn, Olivia, Riley, Duncan, Finlay-Schultz, Jessica, Paul, Kiran V, Kabos, Peter, Sartorius, Carol A

    Published in Molecular cancer research (02-09-2022)
    “…Basal-like breast cancers (BLBC) are the most common triple-negative subtype (hormone receptor and HER2 negative) with poor short-term disease outcome and are…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Degenerate minigene library analysis enables identification of altered branch point utilization by mutant splicing factor 3B1 (SF3B1) by Gupta, Abhishek K, Murthy, Tushar, Paul, Kiran V, Ramirez, Oscar, Fisher, Joseph B, Rao, Sridhar, Rosenberg, Alexander B, Seelig, Georg, Minella, Alex C, Pillai, Manoj M

    Published in Nucleic acids research (25-01-2019)
    “…Abstract Cancer-associated mutations of the core splicing factor 3 B1 (SF3B1) result in selection of novel 3′ splice sites (3′SS), but precise molecular…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    The Development and Use of Scalable Systems for Studying Aberrant Splicing in SF3B1-Mutant CLL by Murthy, Tushar, Paul, Kiran V, Minella, Alexander C, Pillai, Manoj M

    “…Mutational landscape of CLL is now known to include recurrent non-synonymous mutations in SF3B1, a core splicing factor. About 5-10% of newly diagnosed CLL…”
    Get more information
    Journal Article
  12. 12

    Abstract 5291: OncoMD: A powerful genomics data analysis and interpretation platform for cancer discovery research by Gupta, Ravi, Paul, Kiran V., Kumaramangalam, Kartik, Santhosh, Sam, Chaudhuri, Amitabha

    Published in Cancer research (Chicago, Ill.) (15-07-2016)
    “…Abstract Cancer cells gain fitness advantage over normal cells by accumulating mutations over time. Next Generation DNA sequencing technologies have made the…”
    Get full text
    Journal Article
  13. 13

    Estrogens and Progestins Cooperatively Shift Breast Cancer Cell Metabolism by Ward, Ashley V, Matthews, Shawna B, Fettig, Lynsey M, Riley, Duncan, Finlay-Schultz, Jessica, Paul, Kiran V, Jackman, Matthew, Kabos, Peter, MacLean, Paul S, Sartorius, Carol A

    Published in Cancers (31-03-2022)
    “…Metabolic reprogramming remains largely understudied in relation to hormones in estrogen receptor (ER) and progesterone receptor (PR) positive breast cancer…”
    Get full text
    Journal Article
  14. 14

    A Near-Chromosome Level Genome Assembly of Anopheles stephensi by Chida, Afiya Razia, Ravi, Samathmika, Jayaprasad, Suvratha, Paul, Kiran, Saha, Jaysmita, Suresh, Chinjusha, Whadgar, Saurabh, Kumar, Naveen, Rao K, Raksha, Ghosh, Chaitali, Choudhary, Bibha, Subramani, Suresh, Srinivasan, Subhashini

    Published in Frontiers in genetics (16-11-2020)
    “…Malaria remains a major healthcare risk to growing economies like India, and a chromosome-level reference genome of is critical for successful vector…”
    Get full text
    Journal Article
  15. 15

    Integrative genome-wide analysis reveals EIF3A as a key downstream regulator of translational repressor protein Musashi 2 (MSI2) by Karmakar, Shilpita, Ramirez, Oscar, Paul, Kiran V, Gupta, Abhishek K, Kumari, Vandana, Botti, Valentina, de Los Mozos, Igor Ruiz, Neuenkirchen, Nils, Ross, Robert J, Karanicolas, John, Neugebauer, Karla M, Pillai, Manoj M

    Published in NAR cancer (01-06-2022)
    “…Musashi 2 (MSI2) is an RNA binding protein (RBP) that regulates asymmetric cell division and cell fate decisions in normal and cancer stem cells. MSI2 appears…”
    Get full text
    Journal Article
  16. 16

    Impact of percutaneous coronary intervention in the right coronary artery on right ventricular function in patients with acute myocardial infarction by Kiran, Ganthala, Santosh, T, John, Grace, Rao, M

    Published in Journal of Indian College of Cardiology (01-01-2023)
    “…Background: Right ventricular (RV) dysfunction is a potent predictor of mortality and morbidity after acute myocardial infarction (MI). Even though elective…”
    Get full text
    Journal Article
  17. 17

    Abstract 2605: Cytokeratin 5 promotes endocytosis to remodel cell adhesions in breast cancer by McGinn, Olivia Frances, Ward, Ashley V., Finlay-Schultz, Jessica, Paul, Kiran Vinod, Kabos, Peter, Sartorius, Carol

    Published in Cancer research (Chicago, Ill.) (15-08-2020)
    “…Abstract Breast cancer (BC) is clinically classified according to expression of estrogen receptor, progesterone receptor (ER+ BC), HER2 (HER2+), or absence of…”
    Get full text
    Journal Article
  18. 18

    Cloud IoT Based Surveillance System for Tracking and Monitoring of Domestic Animals by Manikanta, Ande NagaSai, Baba, Abdul Farid, Vyshnavi, Devarakonda Srivalli, Paul, Dondapati Kiran, Sreedhar P, Siva Satya

    “…The global practice of domesticating animals for rearing in residential settings is currently experiencing a significant surge. Animals have become an…”
    Get full text
    Conference Proceeding
  19. 19

    Cytokeratin 5 alters [beta]-catenin dynamics in breast cancer cells by McGinn, Olivia, Ward, Ashley V, Fettig, Lynsey M, Riley, Duncan, Ivie, Joshua, Paul, Kiran V, Kabos, Peter

    Published in Oncogene (01-03-2020)
    “…Estrogen receptor (ER) positive breast cancers often contain subpopulations of cells that express the intermediate filament protein cytokeratin 5 (CK5). CK5+…”
    Get full text
    Journal Article
  20. 20